HomeVALN • NASDAQ
add
Valneva SE
Previous close
$10.47
Day range
$11.10 - $11.53
Year range
$3.62 - $11.53
Market cap
967.79M USD
Avg Volume
65.97K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 48.33M | 26.98% |
Operating expense | 17.36M | -84.28% |
Net income | -11.59M | 53.53% |
Net profit margin | -23.97 | 63.41% |
Earnings per share | -0.16 | 56.41% |
EBITDA | -5.23M | 95.14% |
Effective tax rate | 1.89% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 161.31M | 22.75% |
Total assets | 472.62M | 1.30% |
Total liabilities | 286.19M | -4.69% |
Total equity | 186.43M | — |
Shares outstanding | 166.41M | — |
Price to book | 9.35 | — |
Return on assets | -5.57% | — |
Return on capital | -6.91% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -11.59M | 53.53% |
Cash from operations | -2.80M | 92.61% |
Cash from investing | -681.00K | -176.09% |
Cash from financing | 14.88M | 262.95% |
Net change in cash | 8.32M | 118.39% |
Free cash flow | 7.86M | 109.77% |
About
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
700
